Table 1 Antimicrobial susceptibility of the oral Enterococci
From: Antibiotic resistance and adhesion properties of oral Enterococci associated to dental caries
Antibiotics | No. (%)a of resistant strains | |||
|---|---|---|---|---|
| Â | E. faecalis(n = 17) | E. faecium(n = 4) | Total (n = 21) | |
PENICILLINS | P | 17 (100) | 4 (100) | 21 (100) |
| Â | Amx | 6 (35) | 0(0) | 6 (29) |
| Â | AM | 6 (35) | 1 (25) | 7 (33) |
| Â | AMC | 4 (25) | 1 (25) | 5 (24) |
| Â | TIC | 17 (100) | 4 (100) | 21 (100) |
CEPHALOSPORINS | CF | 0(0) | 0 (0) | 0 (0) |
| Â | CFS | 17 (100) | 4 (100) | 21 (100) |
| Â | CAZ | 17 (100) | 4 (100) | 21 (100) |
AMINOGLYCOSIDS | AN | 17 (100) | 4 (100) | 21 (100) |
| Â | GM | 4 (25) | 1 (25) | 5 (24) |
| Â | K | 5 (29) | 0 (0) | 5 (24) |
| Â | TM | 17 (100) | 4 (100) | 21 (100) |
| Â | S | 17 (100) | 4 (100) | 21 (100) |
MACROLIDS | E | 17 (100) | 4 (100) | 21 (100) |
LINCOSAMIDS | L | 17 (100) | 4 (100) | 21 (100) |
POLYPEPTIDS | B | 17 (100) | 4 (100) | 21 (100) |
| Â | CS | 16 (94) | 4 (100) | 20 (95) |
SULFAMIDS-TRIMETHOPRIME | SXT | 12 (71) | 3 (75) | 15 (71) |
GLYCOPEPTIDS | VA | 0 (0) | 0 (0) | 0 (0) |
QUINOLONES | NA | 17 (100) | 4 (100) | 21 (100) |
FLUOROQUINOLONES | CIP | 17 (100) | 4 (100) | 21 (100) |
| Â | OFX | 17 (100) | 4 (100) | 21 (100) |
DIVERS | NI | 17 (100) | 4 (100) | 21 (100) |